Skip to main content
. 2022 Dec 7;17(12):e0277401. doi: 10.1371/journal.pone.0277401

Table 1. Study population characteristics.

Group Bacterial Viral P value
n 181 83
Age, y (± STD) 57.79 (18.9) 43.4 (19.1) <0.001
Sex, male 110 (60.8%) 56 (67.5%) 0.225
BMI, kg/m2 (± STD) 24.0 (3.1) 23.7 (4.2) 0.500
Time from symptoms, h median (IQR) 96 (48–168) 96 (48–168) <0.001
Dyslipidemia, % 37.6 18.1 <0.001
Hypertension, % 43.7 21.7 <0.001
CRP admission, median (IQR) 133 (48.99–192.26) 23.31 (8.72–53) <0. 001
eCRPv, median (IQR) 1.1 (0.4–2.61) 0.25 (0.05–0.78) <0. 001
WBC, 109/L median (IQR) 11.3 (8.4–14.28) 6.85 (5.07–10.43) <0. 001
Neutrophil, % median (IQR) 79 (72–87) 68 (50–79) <0. 001
Lymphocytes, % median (IQR) 13 (8–20) 22 (12–42) <0.001
PLT, 109/L, median (IQR) 224 (173.5–280) 179 (150–217) <0.0001

BMI = body mass index, CRP = C-reactive protein, eCRPv = estimated C-reactive protein velocity, WBC = white blood cells, PLT = platelets, IQR = interquartile range, STD = standard deviation.